- 2024-09-26
医療ガスおよび医療機器市場 – 2029年までの世界予測
Report Overview The medical gas and equipment market is projected to reach USD 26.44 billion by 2029 from USD 19.90 billion in 2024, at a CAGR of 5.8% […]
CATEGORY
医療・医薬
- 2024-09-20
医療用放射線検出、監視、安全性市場 – 2029年までの世界予測
Report Overview The value of the global medical radiation detection, monitoring & safety market, estimated at around USD 1.26 Billion in 2024, is […]
- 2024-09-19
画像誘導およびロボット支援手術市場の成長と動向分析レポート
Image-Guided And Robot-Assisted Surgical Procedures Market Growth & Trends The global image-guided and robot-assisted surgical procedures market s […]
- 2024-09-19
SPRIFERMIN – 変形性関節症治療薬のパイプライン
Report Overview KEY INSIGHTS Sprifermin (AS-902330) is a recombinant version of human fibroblast growth factor 18 (FGF18). Sprifermin acts as a strong […]
- 2024-09-19
TLC599 – 変形性関節症治療薬のパイプライン – 市場インサイトと2032年までの予測
Report Overview KEY INSIGHTS TLC599 is a proprietary formulation of dexamethasone sodium phosphate (DSP) utilizing the BioSeizer technology, designed […]
- 2024-09-19
ウゴービ – 変形性関節症治療薬のパイプライン
Report Overview KEY INSIGHTS WEGOVY (Semaglutide) is a synthetic version of the human glucagon-like peptide-1 (GLP-1) hormone. It promotes weight loss […]
- 2024-09-19
X0002 – 変形性関節症治療薬のパイプライン – 市場インサイトと2032年までの予測
Report Overview KEY INSIGHTS X0002, also known as ibuprofenamine hydrochloride spray, is an innovative transdermal non-steroidal anti-inflammatory dru […]
- 2024-09-19
ZILOSUL – 変形性関節症治療薬のパイプライン – 市場インサイトと2032年までの予測
Report Overview KEY INSIGHTS ZILOSUL, also known as pentosan polysulfate sodium (PPS), is a semi-synthetic medication derived from the wood chips of E […]
- 2024-09-19
AMZ001 – 変形性関節症治療薬のパイプライン
Report Overview KEY INSIGHTS AMZ001 is a new topical gel formulation of diclofenac, developed specifically to treat knee osteoarthritis (OA) pain. Wit […]
- 2024-09-19
CNTX-4975 – 変形性関節症治療薬のパイプライン
Report Overview KEY INSIGHTS CNTX-4975 is currently being evaluated as a treatment for moderate to severe knee osteoarthritis (OA) pain. It is a highl […]
- 2024-09-19
ELIXCYTE – 変形性関節症治療薬のパイプライン – 市場インサイトと2032年までの予測
Report Overview KEY INSIGHTS ELIXCYTE is an allogeneic stem cell product derived from adipose tissue, designed to regulate the immune system, reduce i […]
- 2024-09-19
INVOSSA – 変形性関節症治療薬のパイプライン – 市場インサイトと2032年までの予測
Report Overview KEY INSIGHTS INVOSSA is a groundbreaking cell and gene therapy designed to treat knee osteoarthritis with a single intra-articular inj […]